Image

Cardiopulmonary Rehabilitation In Heart Valve Surgery

Cardiopulmonary Rehabilitation In Heart Valve Surgery

Recruiting
25-75 years
All
Phase N/A

Powered by AI

Overview

The aim of this study was to investigate the effects of postoperative early mobilization and Bottle-P.E.P. application on respiratory parameters and functional capacity in patients undergoing heart valve surgery.

Description

After all patients were informed about the study and potential risks, patients who gave informed consent will be evaluated preoperatively and 5-7 days after surgery by the same investigator. Patients will be randomly divided into 3 groups: Group I (n=20, control) - conventional cardiopulmonary rehabilitation, Group II (n=20), conventional cardiopulmonary rehabilitation and Bottle P.E.P. application, Group III (n=20) will be included in the study as conventional cardiopulmonary rehabilitation and early mobilization group. The respiratory parameters of the patients will be determined by a pulmonary function test and their functional capacities will be determined by a 6-minute walk test. The preoperative and postoperative periods will be compared with statistical methods in the light of these evaluations on days 5-7.

Eligibility

Inclusion Criteria:

  • After heart valve surgery: Patients undergoing valvular surgery via sternotomy
  • Same surgical technique (from med-sternum)
  • Age group (25-75 Y)
  • Stable hemodynamic values (stable vital signs, normal temperature, etc.)
  • Full awareness of time and space

Exclusion Criteria:

  • Ejection Fraction 35 %
  • Any Male/female patient <25 or >75
  • Body Mass Index (BMI) ≥ 38 kg/m2
  • Intubation time >6 hours after surgery
  • Uncontrolled arrhythmias
  • Rheumatoid arthritis, other inflammatory and autoimmune diseases
  • Active malignancy
  • Cardiac pacemaker or defibrillator
  • Mental health disorders
  • Any postoperative complication (general muscle weakness, wound infection of the sternum or leg, stroke.)
  • Refusal to assist in data collection

Study details
    Heart Valve Diseases

NCT06493123

Istanbul Saglik Bilimleri University

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.